{
    "title": "FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10653535/FDA-says-current-dose-GSK-Vir-COVID-therapy-likely-not-effective-against-BA-2-variant.html",
    "date": "2022-03-25",
    "keywords": [
        "ba2",
        "vir",
        "sotrovimab",
        "covid19",
        "therapy",
        "friday",
        "dose",
        "antibody",
        "omicron",
        "subvariant",
        "gsk",
        "variant",
        "fda",
        "march",
        "health",
        "regulator",
        "glaxosmithkline",
        "biotechnologys",
        "agency",
        "authorization",
        "government",
        "week",
        "trading",
        "package",
        "support",
        "mg",
        "data",
        "world",
        "discussion",
        "move",
        "blow",
        "demand",
        "treatment",
        "activity",
        "columbia",
        "university",
        "lillys",
        "bebtelovimab",
        "merck",
        "disease",
        "control",
        "prevention",
        "cdc",
        "frequency",
        "connecticut",
        "maine",
        "hampshire",
        "rhode",
        "island",
        "york",
        "puerto",
        "rico",
        "virgin",
        "result",
        "office",
        "assistant",
        "secretary",
        "preparedness",
        "response",
        "distribution",
        "notice",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}